ClinicalTrials.Veeva

Menu

Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype

D

Denver Health and Hospital Authority

Status

Enrolling

Conditions

Vomiting
Eating Disorders
Barrett Esophagus
Esophageal Adenocarcinoma
Rumination
Anorexia Nervosa, Binge Eating/Purging Type

Treatments

Device: EsoGuard

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT06532734
24-0349

Details and patient eligibility

About

To better define the presence of Barrett's esophagus (BE) via non-endoscopic testing in an eating disorder cohort with purging (vomiting/rumination) behaviors

Full description

A prospective cohort study to assess the presence of BE in those with purging behaviors from their eating disorders has not been completed. There are multiple case reports describing a younger population not meeting typical screening guidelines whom developed this condition. To better define the presence of Barrett's esophagus (BE) via non-endoscopic testing in an eating disorder cohort with purging (vomiting/rumination) behaviors. Individuals with severe forms of eating disorders with purging and ruminating behaviors not meeting the current screening guidelines for BE will still test positive for BE.

Enrollment

25 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with an eating disorder diagnosis that includes purging history
  • Ages 18-65
  • Purging history =>5 years
  • Purging or rumination at a minimum of once daily upon admission.
  • Admission to the ACUTE Center for Eating Disorders and Severe Malnutrition

Exclusion criteria

  • Any eating disorder diagnosis that does not include purging behaviors
  • Ages under 18 and over 65
  • Patients who otherwise meet the current ACG screening guidelines (chronic GERD and 3 or more risk factors for Barrett's mentioned in the Background)
  • Received mandated care at time of enrollment
  • Inability to consent to participate in the research

Trial design

25 participants in 1 patient group

AN-BP
Description:
individuals with a dx of AN-BP, with a \>5-year history of purging, with a frequency of at least once a day.
Treatment:
Device: EsoGuard

Trial contacts and locations

2

Loading...

Central trial contact

Marina J Foster, BA; Allison Nitsch, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems